Detected ·

Biossil

——

Biossil raised US$43M led by Founders Fund and OpenAI. The company uses proprietary GEMOD technology to identify patient subgroups for discontinued drugs and advance them through targeted clinical trials.

Amount
—
Stage
—
Event
Funding round
Detected
2026-04-20 18:09:41 UTC
Signal ID
218d1d75-faa9-4ae8-8dab-26a6335272fb

As the API returns it

{
  "id": "218d1d75-faa9-4ae8-8dab-26a6335272fb",
  "created_at": "2026-04-20T18:09:41.046907Z",
  "company_name": "Biossil",
  "company_website_url": "www.biossil.co",
  "company_linkedin_url": "https://www.linkedin.com/company/biossil-ai",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Biossil raised US$43M led by Founders Fund and OpenAI. The company uses proprietary GEMOD technology to identify patient subgroups for discontinued drugs and advance them through targeted clinical trials.*"
}

Latest rounds